Abstract Dominant optic atrophy, Kjer type, is an autosomal dominant disorder causing progressive loss of visual acuity and colour vision from early childhood. The gene (OPA1) has variable expressivity, a penetrance of 0.98, and the locus has been localised to 3q28-29. We have genotyped nine British families with the disease using 12 polymorphic microsatellite markers from this region. Linkage and haplotype analysis shows the OPAl gene to be located in a 2.3 cM interval between markers D3S1601 and D3S2748. One family showed no evidence of linkage with the chromosome 3 markers, suggesting for the first time that locus heterogeneity for this disease may exist, although exclusion for linkage is based on unaffected subjects. In addition, analysis of recombinants has enabled us to order the 12 markers along chromosome 3.
Kjer type juvenile optic atrophy (MIM 165500)' is an autosomal dominant disorder, believed to have a frequency of around 1 in 50 OO0.2 Described first by Kjer,' it arises in childhood before the age of about 8 years with insidious onset of symptoms and has a slowly progressive course. There is a variable reduction in visual acuity, loss of colour perception, characteristically in the blue-yellow axis, and temporal or diffuse disc pallor.4" Pathological studies suggest that the retinal ganglion cells are affected.7 8 The gene (OPAl) appears to have variable expression, for the phenotype ranges from mild visual impairment to severe: some people continue to lead a normal life while others are registered as blind. In 1994, the gene was mapped to the telomeric region of 3q by Eiberg et at in three large Danish pedigrees. Refinement of the position to 3q28-29 was achieved in a large Cuban family'0 and subsequently in four French families" and in a single multigenerational American family.'2 We previously confirmed the localisation of the OPAl gene to the same region of chromosome 3 in a large multigeneration extended British pedigree" using seven microsatellite markers. Votruba et al '4 have recently published similar data on their British families. The original Danish group has now refined the OPAl locus to a 1.4 cM interval. '5 All the studies so far have suggested that the penetrance is almost full (0.98) and there is no genetic heterogeneity in this disorder. We now present our findings using 12 polymorphic microsatellite markers from 3q28-q29 in nine British families, in which we suggest for the first time that locus heterogeneity may exist for this disorder.
Materials and methods
Blood or mouthwash samples were obtained from 108 members of nine British families (pedigrees shown in fig 1) residing in London and the Home Counties, the Midlands, and south west England. They were visited at home by either of two ophthalmologists with neurophthalmic expertise. Subjects were classified as definitely affected, possibly affected, or not affected using a protocol which had been validated in our earlier study.'3 It was based on the following features: insidious onset under 10 years of age; apparent autosomal dominant inheritance; reduced Snellen visual acuity; temporal or diffuse pallor of the optic disc; reduced colour vision using Ishihara and HRR plates; and centrocecal desaturation of a red target on confrontation field testing. Particular weight was given to the presence of temporal or diffuse optic disc pallor even in the absence of visual acuity or significant colour vision defects when the person was part of a pedigree with known autosomal dominant optic atrophy. Children were examined but not all were able to provide samples. The assignment of clinical status was made before the DNA studies.
Genomic DNA was prepared using a "Puregene" DNA isolation kit (Gentra Systems Inc). Twelve polymorphic microsatellite markers located in 3q27-3q29 were used for genotyping: D3S1314, D3S2747, D3S1601, D3S2418, D3S3669, D3S2305, D3S3562, D3S3590, D3S2748, D33S1305, D3S3642, and D3S1265. The oligonucleotide sequences of the primer pair of each were obtained from Genethon (http://www.genethon.fr) or the Genome Database (http://gdbwww.gdb.org), and HPLC purified primers with the 5' end fluorescently labelled were made (Oswel DNA Services, Southampton, UK). PCR of the genomic DNA (100 ng) was performed with 10 pmol of each primer, 5 gmol/l of each deoxynucleotide triphosphate, 0.5 U Taq polymerase, 1.5 mmol/l magnesium chloride, and standard Taq polymerase buffer (Promega Corporation, Southampton, UK) using 35 amplification cycles of 94°C for 40 seconds and 55°C for one minute, and a final extension GENEHUNTER'9 and homogeneity analysis was performed using the HOMOG program of the LINKAGE package. 20 The marker order suggested by pedigree data from this study was determined using CRI-IAP"2 and compared to that given by the latest The order of the 12 chromosome 3 markers and the intermarker distances were estimated based on marker genotypes from all families and are shown on the left side offig 3. The best order is cen-D3S1314-D3S2747-D3S1601-D3S2418 -D3S3669 -D3S2305 -D3S3562 -D3S3590 -D3S2748 -D3S1305 -D3S3642 -D3S1265-tel. This broadly corresponds to the 1996 Genethon map22 and that of Cedar Genetics; however, recombinant events have allowed us to order several markers not specified on this map and to integrate the two markers we have used derived from Cedar Genetics. A crossover in subject 5/III.14 ( fig 3) places D3S2747 telomeric to D3S1314, and recombinants from two separate meioses (in 1/II.10 and 1/IV.6, fig 3) place D3S2418 telomeric to D3S1601. A crossover in 2/III.6 ( fig  4) orders D3S2305 telomeric to D3S3669, and one in 2/IV.6 (fig 4) orders D3S2305 centromeric to D3S3562. D3S3590 is ordered centromeric to D3S2748 by a recombinant in 4/IV.4 ( fig 3) and D3S1305 centromeric to D3S3642 by a crossover in subject 5/III.12 (data not shown).
Our order is the same as that arrived at by Brown et al'2 in American families, but differs from that found in Danish families,'5 our order compared with that of the Danish workers fitting our data significantly better with odds greater than 1: 100.
In the eight families where the disease mapped to chromosome 3, there were four subjects who were considered to be possibly affected: three members of family 5 (III.12, IV.8, and IV. 10) and V.8 in family 9. All except 5/IV. 10 were found to bear the complete haplotype segregating with the disease in their family; 5/IV. 10 was a recombinant, but only at the most proximal locus D3S1314 (fig 3) 6 , and III.6 had the classical stigmata of dominant optic atrophy. Subjects III.2 and IV.1, though clearly affected, with disc pallor and significantly defective colour vision, had visual acuity within the normal range. Subjects IV.3 and IV.4 (aged 13 and 10 years) were clinically very similar, having excellent visual acuity but mildly defective colour vision and minimal temporal pallor of the optic discs. They were both classified clinically as possibly affected. Subjects II.3, III.7, and IV.2 had an entirely normal examination and were regarded as unaffected. The absence of any other neurological, developmental, or congenital abnormalities is thought by many to be part of the clinical picture of dominant optic atrophy, although Hoyt4 has described sensorineural hearing loss as an association, and Kjer3 noted mental retardation in 10% of his cases. No subject in family 2 had subjective hearing difficulties and there were no subjects with mental retardation, although a detailed neurological examination was not performed. The clinical picture in affected members of family 2 was similar to that of affected members of the other families in the study.
On haplotype analysis, a haplotype segregated with the disease in subjects I.1, I.6, and III.2, but was also found in III.7 and IV.2 (aged 25 years and 16 years respectively), who were clinically clearly unaffected, and in one of the latter's possibly affected brothers (IV.3) but not the other (IV.4) (table 2). A recombinant at locus D3S2305 was present in affected III.6 and her two offspring, IV.5 and IV.6, the former aged 6 being affected, while the latter was only 3 years and although the clinical examination was incomplete, he was considered possibly affected. The genotyping in these subjects was repeated on two separate DNA samples from each person and no inconsistencies were found.
While in this family there is no affected subject without at least part of the haplotype associated with the disease, there is statistically significant evidence on homogeneity analysis for a lack of linkage of the disease to chromosome 3. Thus the evidence against linkage comes essentially from unaffected subjects and this is always less satisfactory than from affected subjects because of the issue of non-penetrance. However, in none of the other eight families studied was a non-penetrant carrier found, so this clustering of two such cases in one pedigree is striking. It is therefore possible that this family has another form of dominant optic atrophy, the locus of which is elsewhere in the genome. This is the first suggestion that locus heterogeneity might exist for dominant optic atrophy, Kjer type.
